Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b₅ binding site and comparisons with CYP2B1 and CYP2B4

References

• AOYAMA, T., KORZEKWA, K., NAGATA, K., ADESNIK, M., REISS, A., LAPENSON, D. P., GILLETTE, J., GELBOIN, H. V., WAXMAN, D. J. and GONZALEZ, F. J., 1989, Sequence requirements for cytochrome P450IIB1 catalytic activity. Journal of Biological Chemistry, 264, 21327–21333.
   PubMed Web of Science ®Google Scholar
• ARCHAKOV, A. I. and BACHMANOVA, G. I., 1990, Cytochrome P450 and Active Oxygen (London: Taylor & Francis).
   Google Scholar
• BAKER, M. T., OLSON, M. J., WANG, Y., RONNENBERG, W. C., JOHNSON, J. T. and BRADY, A. N., 1995, Isoflurane-chlorodifluoroethene interaction in human liver microsomes: role of cytochrome P4502B6 in potentiation of haloethene metabolism. Drug Metabolism and Disposition, 23, 60–64.
   PubMed Web of Science ®Google Scholar
• BAYLISS, M. K., BELL, J. A., WILSON, K. and PARK, G. R., 1994, 7-ethoxycoumarin 0-deethylase kinetics in isolated rat, dog and human hepatocyte suspensions. Xenobiotka, 24, 231–241.
   PubMed Web of Science ®Google Scholar
• BERNHARDT, R., 1995, Cytochrome P450: structure, function and generation of reactive oxygen species. Reviews of Physiology, Biochemistry and Pharmacology, 127, 137–221.
   Web of Science ®Google Scholar
• BERNHARDT, R., KRAFT, R. and RUCKPAUL, K., 1989, Molecular mechanism of P450-reductase interaction. In I. Schuster (ed.), Cytochrome P450 — Biochemistry and Biophysics (London: Taylor & Francis), pp. 320–323.
   Google Scholar
• BLANCK, J., REIN, H., SOMMER, M., RISTAU, 0., SMETTAN, G. and RUCKPAUL, K., 1983, Correlations between spin equilibrium shift, reduction rate and N-demethylation activity in liver microsomal cytochrome P450 and a series of benzphetamine analogues as substrates. Biochemical Phar-macology, 32, 1683–1688.
   Google Scholar
• BORN, S. L., JOHN, G. H., HARLOW, G. R. and HALPERT, J. R., 1995, Characterization of the progesterone 21-hydroxylase activity of canine cytochrome P450 PBD-2/P450 2B11 through reconstitution, heterologous expression and site-directed mutagenesis. Drug Metabolism and Disposition, 23, 702–707.
   PubMedGoogle Scholar
• CAMOLLE, G. P., SHARKAWI, M., DUCHARME, J., MADAN, A., SANZGHIRI, U., PARKINSON, A. and WAINER, I. W., 1996, Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of ifosfamide. In ISSX Proceedings, 7th North American ISSX Meeting, San Diego, 20–25 October, 1996, vol. 10, 361 P.•
   Google Scholar
• CHANG, T. K. H., GONZALEZ, F. J. and WAXMAN, D. J., 1994, Evaluation of triacetyloleandomycin, a-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Archives of Biochemistry and Biophysics, 311, 437–442.
   Google Scholar
• CHANG, T. K. H., WEBER, G. F., CRESPI, C. L. and WAXMAN, D. J., 1993, Differential activation of cyclophosphamide and iphosphamide by cytochromes P450 2B and 3A in human liver miscosomes. Cancer Research, 53, 5629–5637.
   Google Scholar
• CHANG, Y.-T., STIFFELMAN, P. B., VASKER, I. A., LOEW, G. H., BRIDGES, A. and WASICEL L., 1997, Construction of a 3D model of cytochrome P4502B4. Protein Engineering, 10, 119–129.
   PubMedGoogle Scholar
• CODE, E. L., CRESPI, C. L., PENMAN, B. W., GONZALEZ, F. J., CHANG, T. K. H. and WAXMAN, D. J., 1997, Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity and role in procarcinogen activation. Drug Metabolism and Disposition, 25, 985–993.
   Google Scholar
• DE LEMOS -CHIARANDINI, C., FRY, A. B., SABATINI, D. D. and KREIBACH, G., 1987, Determination of the membrane topology of the phenobarbital-inducible rat liver cytochrome P450 isozyme PB-4 using site-specific antibodies. Journal of Cell Biology, 104, 209–219.
   Google Scholar
• DEHAL, S. S. and KUPFER, D., 1994, Metabolism of the proestrogenic pesticide methoxychlor by hepatic P450 monooxygenases in rats and humans. Drug Metabolism and Disposition, 22, 937–946.
   PubMed Web of Science ®Google Scholar
• DELucA, J. G., DYSART, G. R., RASNICK, D. and BRADLEY, M. 0., 1988, A direct, highly sensitive assay for cytochrome P450 catalysed 0-deethylation using a novel coumarin analog. Biochemical Pharmacology, 37, 1731–1739.
   Google Scholar
• EKINS, S., VANDEN BRANDEN, M., GILLESPIE, J. S., RING, B. J., WRIGHTON, S. A. and WIKEL, J. H., 1997, A preliminary substrate pharmacophore for CYP2B6. In Proceedings of the 8th ISSX North American Meeting, South Carolina, 6–30 October, 1997, vol. 12, p. 63.
   Google Scholar
• EKINS, S., VANDEN BRANDEN, M., RING, B. J. and WRIGHTON, S. A., 1996, Kinetic and inhibition characteristics on CYP2B6. In ISSX Proceedings, 7th North American ISSX Meeting, San Diego, 20–25 October, vol. 10, p. 232.
   Google Scholar
• ELDIRDIRI, N., 1992, Uptake and metabolic effects of some halogenoalkanes, PhD thesis, University of Surrey, Guildford.
   Google Scholar
• ENGEL, G., HOFMAN, U., HEIDEMAN, H., COSME, J. and EICHELBAU M., 1996, Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxyantipyrine and 4-norantipyrine. Clinical Pharmacology and Thera-peutics, 59, 613–623.
   PubMed Web of Science ®Google Scholar
• EPSTEIN, P. M., CURTI, M., JANSSON, I., HUANG, C.-H. and SCHENICMAN, J. B., 1989, Phosphorylation of cytochrome P450: regulation by cytochrome b„ Archives of Biochemistry and Biophysics, 271, 424–432.
   Google Scholar
• FUNAE, Y. and IMAOKA, S., 1993, Cytochrome P450 in rodents. In J. B. Schenkman and H. Griem (eds) Cytochrome P450 (Berlin: Springer), pp. 221–238.
   Google Scholar
• GIBSON, G. G. and SKETT, P., 1994, An Introduction to Drug Metabolism (London: Chapman & Hall). GOLLY, I. and HLAVICA, P., 1992, Chemical modification of lysine residues in cytochrome P450LM2 (P450IIB4): influence on heme liganding of arylamines. Archives of Biochemistry and Biophysics, 292, 287–294.
   Google Scholar
• GONZALEZ, F. J., 1992, Human cytochromes P450: problems and prospects. Trends in Biochemical Sciences, 13, 346–352.
   Google Scholar
• GONZALEZ, F. J. and GELBOIN, H. V., 1994, Role of human cytochromes P450 in the metabolism activation of chemical carcinogens and toxins. Drug Metabolism Reviews, 26, 165–183.
   PubMed Web of Science ®Google Scholar
• GONZALEZ, F. J. and LEE, Y. H., 1996, Constitutive expression of hepatic cytochrome P450 genes. F ASEB Journal, 10, 1112–1117.
   PubMed Web of Science ®Google Scholar
• GOTOH, 0., 1992, Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. Journal of Biological Chemistry, 267, 83–90.
   Google Scholar
• GRIMM, S. W., DYROFF, M. C., PHILPOT, R. M. and HALPERT, J. R., 1994, Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism. Molecular Pharmacoogy, 46, 1090–1099.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1995, Human cytochrome P450 enzymes. In P. R. Ortiz de Montellano (ed.), Cytochrome P450 (New York: Plenum), pp. 473–535.
   Google Scholar
• HALPERT, J. R., 1995, Structural basis of selective cytochrome P450 inhibition. Annual Review of Pharmacology and Toxicology, 35, 29–53.
   PubMed Web of Science ®Google Scholar
• HALPERT, J. R. and HE, Y., 1993, Engineering of cytochrome P450 2B1 specificity. Journal of Biological Chemistry, 268, 4453–4457.
   PubMed Web of Science ®Google Scholar
• HARLOW, G. R. and HALPERT, J. R., 1996, Mutagenesis study of Asp-290 in cytochrome P4502B11 using a fusion protein with rat NADPH-cytochrome P450 reductase. Archives of Biochemistry and Biophysics, 326, 85–92.
   PubMedGoogle Scholar
• HARLOW, G. R., HE, Y. A. and HALPERT, J. R., 1997, Functional interaction between amino acid residues 242 and 290 in cytochromes P450 2B1 and 2B11. Biochimica et Biophysica Acta, 1338, 259–266.
   PubMedGoogle Scholar
• HASLER, J . A., HARLOW, G. R., S ZKLARZ, G. D., JOHN, G. H., KEDZ1E, K. M., BURNETT, V. L., HE, Y.-A., KAMINSKY, L. S. and HALPERT, J. R., 1994, Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290 and 363 for substrate specificity. Molecular Pharmacology, 46, 338–345.
   Google Scholar
• HE, Y., Luo, Z., KLEKOTKA, P. A., BURNETT, V. L. and HALPERT, J. R., 1994, Structural determinants of cytochrome P450 2B1 specificity: evidence for five substrate recognition sites. Biochemistry, 33, 4419–4424.
   PubMed Web of Science ®Google Scholar
• HE, Y.-A., BALFOUR, C. A., KEDZ1E, K. M. and HALPERT, J. R., 1992, Role of residue 478 as a determinant of the substrate specificity of cytochrome P4502B1. Biochemistry, 31, 9220–9226.
   PubMed Web of Science ®Google Scholar
• HE, Y. Q., HE, Y.-A. and HALPERT, J. R., 1995, Escherichia coli expression of site-directed mutants of cytochrome P4502B1 from six substrate recognition sites: substrate specificity and inhibitor selectivity studies. Chemical Research in Toxicology, 8, 574–579.
   Google Scholar
• HEYN, H., WHITE, R. B. and STEVENS, J. C., 1996, Catalytic role of cytochrome P4502B6 in N-demethylation of S-mephenytoin. Drug Metabolism and Disposition, 24, 948–954.
   PubMed Web of Science ®Google Scholar
• INGELMAN -SUNDBERG, M., 1986, Cytochrome P-450 organization and membrane interactions. In P. R. Ortiz de Montellano (ed.), Cytochrome P450 (New York: Plenum), pp. 119–160.
   Google Scholar
• JANssoN, I., CURTI, M., EPSTEIN, P.M., PETERSON, J. A. and SCHENKMAN J. B., 1990, Relationship between phosphorylation and cytochrome P450 destruction. Archives of Biochemistry and Biophysics, 283, 285–292.
   Google Scholar
• JOHNSON, E. F., 1992, Mapping determinants of the substrate selectivities of P450 enzymes by site-directed mutagenesis. Trends in Pharmaceutical Sciences, 13, 122–126.
   PubMed Web of Science ®Google Scholar
• Jos, B. C., HAWKSWORTH, G., HORNE, V. A., NEWLANDS, A., MORSMAN, J., TUTE, M. S. and SMITH, D. A., 1996, Putative active site template model for cytochrome P4502C9 (tolubtamide hydroxylase). Drug Metabolism and Disposition, 24, 260–266.
   PubMedGoogle Scholar
• KAMATAKI, T., 1993, Metabolism of xenobiotics. In T. Omura, Y. Ishimura and Y. Fujii-Kuriyama (eds), Cytochrome P450 (Tokyo: Kodansha), pp. 141–158.
   Google Scholar
• KEDZ1E, K. M., BALFOUR, C. A., ESCOBAR, G. Y., GRIMM, S. W., HE, Y., PEPPERL, D. J., REGAN, J. W., STEVENS, J. C. and HALPERT, J. R., 1991, Molecular basis for a functionally unique cytochrome P450IIB1 variant. Journal of Biological Chemistry, 266, 22515–22521.
   PubMedGoogle Scholar
• KOLESANOVA, E. F., KOZIN, S. A., LEMESHKO, A. 0. and ARCHAKOV, A. I., 1994, Epitope mapping of cytochrome P450 2B4 by peptide scanning. Biochemistry and Molecular Biology International, 32, 465–473.
   Google Scholar
• LAKE, B. G., 1987, Preparation and characterisation of microsomal fractions for studies of xenobiotic metabolism. In K. Snell and B. Mullock (eds), Biochemical Toxicology: A Practical Approach (Oxford: IRL), pp. 183–215.
   Google Scholar
• LEWIS, D. F. V., 1995, Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450b..). Xenobiotka, 25, 333–366.
   PubMed Web of Science ®Google Scholar
• LEWIS, D. F. V., 1996, Cytochromes P450: Structure, Function and Mechanism (London: Taylor & Francis).
   Google Scholar
• LEWIS, D. F. V. and LAKE, B. G., 1997, Molecular modelling of mammalian CYP2B isoforms and their interaction with substrates, inhibitors and redox partners. Xenobiotka, 27, 443–478.
   Google Scholar
• LEWIS, D. F. V., EDDERSHAW, P. J., DICKINS, M., TARBIT, M. H. and GOLDFARB, P. S., 1998a, Structural determinants of cytochrome P450 substrate specificity, binding affinity and catalytic rate. Chemico-Biological Interactions 115, 175–199.
   PubMed Web of Science ®Google Scholar
• LEWIS, D. F. V., IOANNIDES, C. and PARKE, D. V., 1998b, An improved and updated version of the COMPACT procedure for the evaluation of P450-mediated chemical activation. Drug Metabolism Reviews, 30, 709–737.
   Google Scholar
• LEWIS, D. F. V., IOANNIDES, C. and PARKE, D. V., 1995b, A quantitative structure—activity relationship study on a series of 10 para-substituted toluenes binding to cytochrome P4502B4 (CYP2B4) and also their hydroxylation rates. Biochemical Pharmacology, 50, 619–625.
   Google Scholar
• LEWIS, D. F. V., LAKE, B. G. and PARKE, D. V., 1995a, Molecular orbital-generated QSARs in an homologous series of alkoxy resorufins and studies of their interactive docking with cytochromes P450. Xenobiotica, 25, 1355–1369.
   Google Scholar
• LI, H. and PouLos, T. L., 1997, The structure of the cytochrome P450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nature Structural Biology, 4, 140–146.
   PubMedGoogle Scholar
• MILLER, J. P., HERBETTE, L. G. and WHITE, R. E., 1996, X-ray diffraction analysis of cytochrome P450 2B4 reconstituted into liposomes. Biochemistry, 35, 1466–1474.
   PubMed Web of Science ®Google Scholar
• MIMURA, M., BABA, T., YAMAZAKI, Y OHMORI, S., INUI Y., GONZALEZ, F. J., GUENGERICH, F. P. and SHIMADA, T., 1993, Characterization of cytochrome P450 2B6 in human liver microsomes. Drug Metabolism and Disposition, 21, 1046–1056.
   Google Scholar
• MODI, S., SUTCLIFFE, M. J., PRIMROSE, W. U., LIAN, L.-Y. and ROBERTS, G. C. K., 1996, The catalytic mechanism of cytochrome P450 BM3 involves a 6 A movement of the bound substrate on reduction. Nature Structural Biology, 3, 414–417.
   Google Scholar
• NEDECHEVA, V. and GUT, I., 1994, P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. Xenobiotka, 24, 1151–1175.
   PubMedGoogle Scholar
• NELSON D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, 0., COON, M. J., FSTABROOK, R. W., GuNsALus, I. C. and NEBERT D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   Google Scholar
• Novis, R. W. and LUBET, R. A., 1996, The CYP2B subfamily. In C. Ioannides (ed.), Cytochromes P450 — Metabolic and Toxicological Aspects (Boca Raton: CRC Press), pp. 135–160.
   Google Scholar
• OGURI, K., KANEKO, H., TANIMOTO, Y., YAMADA, H. and YOSHIMURA, H., 1991, A constitutive form of guinea pig liver cytochrome P450 closely related to phenobarbital inducible P450„„ . Archives of Biochemistry and Biophysics, 287, 105–111.
   PubMed Web of Science ®Google Scholar
• OKEY, A. B., 1990, Enzyme induction in the cytochrome P450 system. Pharmacology and Therapeutics, 45, 241–298.
   PubMed Web of Science ®Google Scholar
• OMATA, Y., SAKAMOTO, H., ROBINSON, R. C., PINCUS, M. R. and FRIEDMAN, F. K., 1994, Specificity of the cytochrome P-450 interaction with cytochrome b„ Biochemical and Biophysical Research Communications, 201, 1090–1095.
   Google Scholar
• ONO, S., HATANAKA, T., MIYZAWA, S., TSUTSUI, M., AOYAMA, T., GONZALEZ, F. J. and SATO, T., 1996, Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6,2C19 and 3A subfamily. Xenobiotka, 26, 1155–1166.
   PubMed Web of Science ®Google Scholar
• PETZOLD, D. R., REIN, H., SCHWARZ, D., SOMMER, M. and RUCKPAUL, K., 1985, Relation between the structure of benzphetamine analogues and their binding properties to cytochrome P450LM2. Biochimica et Biophyska Acta, 829, 253–261.
   PubMed Web of Science ®Google Scholar
• RAVICHANDRAN, K. G., BODDUPALLI, S. S., HASEMANN, C. A., PETERSON, J. A. and DEISENHOFER, J., 1993, Crystal structure of the hemoprotein domain of cytochrome P450BM-3, a prototype for microsomal P450s. Science, 261, 731–736.
   PubMed Web of Science ®Google Scholar
• REIDY, G. F., MEHTA I. and MURRAY, M., 1993, Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P450 and inhibition kinetics. Molecular Pharmacology, 35, 736–743.
   Google Scholar
• RENDIC, S. and DI CARLO, F. J., 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metabolism Reviews, 29, 413–580. ROFFEY, S. J., 1993, Structure—activity relationships in the metabolism of a series of tertiary amines by cytochrome P450. PhD thesis, University of Surrey, Guildford.
   Google Scholar
• Rossi, M., MARKOVITZ, S. and CALLAHAN, T., 1987, Defining the active site of cytochrome P450: the crystal and molecular structure of an inhibitor, SKF-525A. Carcinogenesis, 8, 881-887. RUCKPAUL, K., REIN, H. and BLANCK J., 1989, Regulation mechanisms of the activity of the hepatic endoplasmic cytochrome P450. Frontiers in Biotransformation, 1, 1–65.
   Google Scholar
• RUZICKA, J. A. and RUENITZ, P. C., 1992, Cytochrome P450-mediated N-dechloroethylation of cyclophosphamide and ifosfamide in the rat. Drug Metabolism and Disposition, 20, 770-772. SCHENKMAN J. B., 1992, Steroid metabolism by constitutive cytochromes P450. Journal of Steroid Biochemistry and Molecular Biology, 43, 1023–1030.
   PubMedGoogle Scholar
• SCHULZE, J., LEHNERER, M., LEWIS, D. F. V. and HLAVICA, P., 1998, Amino acid residue Glu-250 has a functional role in the assembly of rabbit liver microsomal cytochrome P450 2B4 (CYP2B4). Biochemistry and Molecular Biology International, 44, 1147–1155.
   Google Scholar
• SCHWARZE, W., BLANCK, J., RISTAU, 0., JANIG, G. R., POMMERENING, K., RUN, H. and RUCKPAUL, K., 1985, Spin state control of cytochrome P450 reduction and catalytic activity in a reconstituted P450LM2 system as induced by a series of benzphetamine analogues. Chemko-Biological Interactions, 54, 127–141.
   Google Scholar
• SHIMADA, T., MIMURA, M., INouE, K., NAKAMURA, S.-I., ODA, H., OHMORI, S. and YAMAZAKI, H., 1997, Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys and humans. Archives of Toxicology, 71, 401–408.
   Google Scholar
• SUGAR, S. G., FILIPOVIC, D. and STAYTON, P. S., 1991, Mutagenesis of cytochromes P450.. and b„ Methods in Enzymology, 206, 31–49.
   PubMedGoogle Scholar
• SMITH, D. A., ACKLAND, M. J. and JONES, B. C., 1997, Properties of cytochrome P450 isoenzymes and their substrates. Part 1: Active site characteristics. Drug Discovery Today, 2, 406-414. SOUCEK, P. and GUT, I., 1992, Cytochromes P450 in rats: structures, functions, properties and relevant human forms. Xenobiotka, 22, 83–103.
   Google Scholar
• STAYTON, P. S. and SLIGAR, S. G., 1990, The cytochrome P450.. binding surface as defined by site-directed mutagenesis and electrostatic modeling. Biochemistry, 29, 7381–7386.
   PubMed Web of Science ®Google Scholar
• STAYTON, P. S., PouLos, T. L. and SLIGAR, S. G., 1989, Putidaredoxin competitively inhibits cytochrome b.,—cytochrome P450.. association: a proposed molecular model for a cytochrome P450.. electron transfer complex. Biochemistry, 28, 8201–8205.
   PubMed Web of Science ®Google Scholar
• STRESSER, D. M., DEHAL, S. S. and KUPFER, D., 1995, Ring hydroxylation of [0-'14] methoxychlor as a probe for liver microsomal CYP2B activity. A potential assay for CYP2B in vivo. ISSX Proceedings, 4th International Meeting, Seattle, 27–31 August, vol. 8, p. 66.
   Google Scholar
• SWANSON, B. A., DUTTON, D. R., LUNETTA J. M., YANG, C. S. and ORTIZ DE MONTELLANO, P. R., 1991, The active sites of cytochromes P450IA1, and IIB1, IIB2 and 11E1. Journal of Biological Chemistry, 266, 19258–19264.
   Google Scholar
• SWANSON, B. A., HALPERT, J. R., BORNHEIM, L. M. and ORTIZ DE MONTELLANO, P. R., 1992, Topological analysis of the active sites of cytochrome P450IIB4 (rabbit), P450IIB10 (mouse) and P450IIB11 (dog) by in situ rearrangement of phenyl—iron complexes. Archives of Biochemistry and Biophysics, 292, 42–46.
   Google Scholar
• SZCZESNA-SKORUPA, E. and KEMPER, B., 1993, An N-terminal glycosylation signal on cytochrome P450 is restricted to the endoplasmic reticulum in a luminal orientation. Journal of Biological Chemistry, 268, 1757–1762.
   Google Scholar
• SZKLARZ, G. D., HE, Y. Q., KEDZIE, K. M., HALPERT, J. R. and BURNETT, V. L., 1996, Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4. Archives of Biochemistry and Biophysics, 327, 308–318.
   PubMedGoogle Scholar
• SZKLARZ, G. D., HE, Y. A. and HALPERT, J. R., 1995, Site-directed mutagenesis as a tool for molecular modeling of cytochrome P450 2B1. Biochemistry, 34, 14312–14322.
   PubMed Web of Science ®Google Scholar
• TESTA, B., 1988, Substrate and product stereoselectivity in monooxygenase-mediated drug activation and inactivation. Biochemical Pharmacology, 37, 85–92.
   PubMed Web of Science ®Google Scholar
• TESTA, B. and JENNER, P., 1981, Inhibitors of cytochrome P-450s and their mechanism of action. Drug Metabolism Reviews, 12, 1–117.
   PubMed Web of Science ®Google Scholar
• TUCK, S. F. and ORTIZ DE MONTELLANO, P. R., 1992, Topological mapping of the active sites of cytochromes P4502B1 and P4502B2 by in situ rearrangement of aryl—iron complexes. Bio-chemistry, 31, 6911–6916.
   Google Scholar
• TUCK, S. F., PETERSON, J. A. and ORTIZ DE MONTELLANO, P. R., 1992, Active site topologies of bacterial cytochromes P450101 (P450c., ), P450108 (P450 ) and P450102 (P450Bm ).Journal of Biological Chemistry, 267, 5614–5620.
   Google Scholar
• UVAROV, V. U., SOTNICHENKO, A. I., VODOVOZOVA, E. L., MOLOTKOVSKY, J. G., KOLESANOVA, E. F., LYULIKIN, Y. A., STIER, A., KRUEGER, V. and ARCHAKOV, A. I., 1994, Determination of membrane-bound fragments of cytochrome P4502B4. European Journal of Biochemistry, 222, 483–489.
   PubMedGoogle Scholar
• VAZ, A. D. N., PERNECKY, S. J., RANER, G. M. and COON, M. J., 1996, Peroxo—iron and oxenoid—iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4. Proceedings of the National Academy of Sciences, USA, 93, 4644–4648.
   Google Scholar
• VERMIER, M., BOENS, N. and HEIRWEIGH, K. P. M., 1992, Interaction of 7-n-alkoxycoumarins with cytochromeP-450 and their partitioning into liposomal membranes. Biochemical Journal, 284, 483–490.
   PubMedGoogle Scholar
• VON WACHENFELDT, C. and JOHNSON, E. F., 1995, Structures of eukaryotic cytochrome P450 enzymes. In P. R. Ortiz de Montellano (ed.), Cytochrome P450 (New York: Plenum), pp. 183–223.
   Google Scholar
• WANG, M., ROBERTS, D. L., PASCHKE, R., SHEA, T. M., MASTERS, B. S. S. and KIM, J.-J. P., 1997, Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proceedings of the National Academy of Sciences,USA, 94, 8411–8416.
   Google Scholar
• WAXMAN, D. J., 1988, Interactions of hepatic cytochromes P450 with steroid hormones. Biochemical Pharmacology, 37, 71–84.
   PubMed Web of Science ®Google Scholar
• WAXMAN, D. J. and AZAROFF, L., 1992, Phenobarbital induction of cytochrome P450 gene expression. Biochemical Journal, 281, 577–592.
   PubMed Web of Science ®Google Scholar
• WAXMAN, D. J., DANNAN, G. A. and GUENGERICH, F. P., 1985, Regulation of rat hepatic cytochrome P450: age-dependent expression, hormonal imprinting and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry, 24, 4409–4417.
   PubMed Web of Science ®Google Scholar
• WELCH, R. M., LAI, A. A. and SCHROEDER, D. M., 1987, Pharmacological significance of the species differences in bupropion metabolism. Xenobiotka, 17, 287–298.
   PubMed Web of Science ®Google Scholar
• WHITE, R. E. and MCCARTHY, M. B., 1986, Active site mechanics of liver microsomal cytochrome P450. Archives of Biochemistry and Biophysics, 246, 19–32.
   PubMed Web of Science ®Google Scholar
• WHITLOCK, J. P. and DENISON, M. S., 1995, Induction of cytochrome P450 enzymes that metabolize xenobiotics. In P. R. Ortiz de Montellano (ed.), Cytochrome P450 (New York: Plenum), pp. 367–390.
   Google Scholar
• WURM, R. M., DuNN, J. A., SILVER, I. S. and PATEL, D. K., 1996, In vitro metabolism of bupropion by human liver microsomes and cDNA expressed human cytochrome P45 Os. In I S SX Proceedings, 7th North American Meeting, San Diego, 20–25 October, vol. 10, p. 371.
   Google Scholar
• YAO, K., FALICK, A. M., PATEL, N. and CORREIA, M. A., 1993, Cumene hydroperoxide-mediated inactivation of cytochrome P4502B1. Journal of Biological Chemistry, 268, 59–65.
   PubMed Web of Science ®Google Scholar
• ZIMNIAK, P. and WAXMAN, D. J., 1993, Liver cytochrome P450 metabolism of endogenous steroid hormones, bile acids and fatty acids. In J. B. Schenkman and H. Griem (eds), Cytochrome P450 (Berlin: Springer), pp. 123–144.
   Google Scholar